Print Page     Close Window     

Investor Overview

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility. CytokineticMore >>

Annual Report & Stockholder Meeting Materials and Information

Oct 27 2016 4:30 p.m. ET
Q3 2016 Cytokinetics, Inc. Earnings Conference Call

© 2015 Cytokinetics, Inc. All rights reserved